A representation of a man holding gains in his palm. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Hastings Technology Metals (ASX:HAS) announced on Wednesday it will execute a renounceable rights issue to raise $22M.

New shares will be priced at 36cps with a 1-for-3 attaching option at 50cps two years post issue.

Eligible shareholders may apply for new shares in addition to their entitlement on the same terms where shortfall is available.

“Under the Rights Issue, eligible existing shareholders are invited to subscribe for nine (9) new fully paid ordinary shares (“New Shares”) for every 20 existing Shares held at the Record Date of Wednesday, 3 April 2024,” the company specified.

Hastings was quick to point out on Wednesday that its own C-Suite will participate in the rights issue.

The ultimate outcome of the $22M raise is for working capital to continue development of its Yangibana REE Project, including the completion of project funding.

The issue is partially underwritten.

“All of the Company’s Board and senior management team intend to take up their entitlement in the Rights Issue, underlining our conviction in the Yangibana Project’s potential to become a world-class rare earth operation,” Hastings Chair Charles Lew said.

“We are pleased to be able to offer our existing shareholders the opportunity to participate in this current funding round which will facilitate the continuation of our project development workstreams for the Yangibana Project.”

HAS last traded at 49.5cps.

HAS by the numbers
More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…